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Abstract
Mobility impairments due to injury or disease have a significant impact on quality of life. Consequently,
development of effective treatments to restore or replace lost function is an important societal challenge. In
current clinical practice, a treatment plan is often selected from a standard menu of options rather than
customized to the unique characteristics of the patient. Furthermore, the treatment selection process is normally
based on subjective clinical experience rather than objective prediction of post-treatment function. The net result is
treatment methods that are less effective than desired at restoring lost function. This paper discusses the possible
use of personalized neuromusculoskeletal computer models to improve customization, objectivity, and ultimately
effectiveness of treatments for mobility impairments. The discussion is based on information gathered from
academic and industrial research sites throughout Europe, and both clinical and technical aspects of personalized
neuromusculoskeletal modeling are explored. On the clinical front, we discuss the purpose and process of
personalized neuromusculoskeletal modeling, the application of personalized models to clinical problems, and gaps
in clinical application. On the technical front, we discuss current capabilities of personalized neuromusculoskeletal
models along with technical gaps that limit future clinical application. We conclude by summarizing
recommendations for future research efforts that would allow personalized neuromusculoskeletal models to make
the greatest impact possible on treatment design for mobility impairments.
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Introduction
Mobility involves walking, stair climbing, posture, bal-
ance, manipulation, transfers, and other locomotion
tasks and is therefore central to qualify of life. When an
individual incurs a mobility impairment, quality of life is
diminished in proportion to the extent of the impair-
ment. For example, mild knee osteoarthritis can limit
participation in desired recreational or athletic activities
without significantly affecting normal daily activities and
productivity. In contrast, a stroke can make it nearly
impossible to walk or manipulate objects, significantly
diminishing an individual’s ability to be self sufficient
and function in society. Spinal cord injury can leave a
person with normal upper extremity function but no
remaining lower extremity function, significantly
impacting only certain aspects of mobility.
Treatments for different mobility impairments are
typically stereotypical, with a standard menu of treat-
ment options existing for any particular mobility impair-
ment. For example, severe medial compartment knee
osteoarthritis may be treated surgically using high tibial
osteotomy, unicondylar knee replacement, or total knee
replacement. Once a patient seeks surgical treatment for
debilitating pain and significant loss of function, the
clinician must choose between these treatment options
based on clinical assessment of the patient. Furthermore,
the clinician must determine the optimal values of the
parameters associated with the selected treatment (e.g.,
method, level, and amount of correction for tibial
osteotomy, and implant type, size, and positioning for
joint replacement). A similar situation exists for
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bral palsy. In clinical practice, the final treatment plan is
usually selected based on subjective clinical experience
rather than on objective prediction of post-treatment
function developed from patient data.
Personalized computational models of the neuromus-
culoskeletal system could facilitate objective prediction
of patient-specific functional outcome for different treat-
ment designs being considered by the clinician. Depend-
ing on the intended clinical application, a personalized
neuromusculoskeletal model could account for patient-
specific anatomical (e.g., skeletal structure and muscle
lines of action), physiological (e.g., muscle force-generat-
ing properties), and/or neurological (e.g., constraints on
achievable muscle excitation patterns) characteristics, all
within the context of a multibody dynamic model. Per-
sonalized models for treatment design are motivated by
the fact that for many treatments, “one size fits none.”
Every patient is different and possesses unique anatomi-
cal, neurological, and functional characteristics that may
significantly impact optimal treatment of the patient.
Personalized models provide one possible avenue for
increased objectivity in treatment planning, reducing the
likelihood that different clinicians will plan different
treatments given the same patient data. Ideally, virtual
treatments performed on a patient’s personalized model
would allow objective and reliable prediction of post-
treatment function and thus identification of an optimal
treatment plan. Such predictions would identify not only
the best type of treatment (including previously
unknown treatments) but also treatment parameters to
which functional outcome is highly sensitive (i.e., which
treatment parameter values does the clinician need to
“get right"?).
This paper explores how personalized neuromusculos-
keletal models could be used to improve treatment
design for mobility impairments. The exploration is
based on a survey of personalized modeling research
being performed in Europe and thus is limited in its
scope. The survey was funded by the National Science
Foundation (NSF) in the United States with the goal of
synthesizing research recommendations and informing
research funding in the area of technology to improve
mobility. In October of 2010, two teams of four pane-
lists recruited by NSF visited a number of academic and
industrial sites throughout Europe over a one week time
period. Since time and financial constraints limited the
number of labs that could be visited, it was not possible
to gather information from all labs in Europe perform-
ing valuable work in this area. Given that the goal of the
tour was to survey the state-of-the-art in Europe, we
also omit discussion of valuable work being performed
by labs outside of Europe. The remainder of this paper
summarizes the panel’s findings related to the potential
clinical use and benefit of personalized neuromusculos-
keletal modeling.
Clinical aspects of personalized modeling
In this section, we discuss current and future clinical
uses of personalized neuromusculoskeletal models to
design improved treatments for mobility impairments.
To set the stage, we begin by discussing common rea-
sons why human movement data are collected, followed
by a proposal for a general process to follow when using
personalized models in the treatment design process.
We then discuss mobility-related clinical problems cur-
rently being addressed with personalized neuromuscu-
loskeletal models, and we conclude this section by
highlighting gaps in clinical application where persona-
lized models could add significant value.
Clinical purpose of personalized modeling
Pre-treatment human movement (e.g., motion capture,
ground reaction, muscle electromyographic, energy
consumption), strength (e.g., isometric and isokinetic
dynamometer), and imaging (e.g., magnetic resonance
(MR), computed tomography (CT), x-ray, fluoro-
scopic) data provide the experimental measurements
necessary to develop objective model-based predic-
tions of post-treatment function. As described by Dr.
Maria Grazia Benedetti at the Rizzoli Orthopedic
Institute in Bologna, Italy, there are three primary rea-
sons for collecting human movement data in a clinical
setting:
1) Assessment - Assess after treatment how the treat-
ment worked for an individual patient or a group of
patients. An example would be using gait data to assess
changes in walking speed and knee flexion angle follow-
ing tendon transfer or lengthening surgery in a specific
child or group of children with cerebral palsy. This use
of human movement data is relatively common.
2) Identification - Identify on an individual patient
basis which patients should be treated (but not how
they should be treated). An example would be using gait
data to determine whether tendon transfer or tendon
lengthening surgery should be performed for a specific
child with cerebral palsy. This use of human movement
data remains uncommon but is becoming more
common.
3) Prediction - Predict on an individual patient basis
which treatment should be performed and how it should
be performed. An example would be using gait data to
determine whether tendon transfer or tendon lengthen-
ing surgery should be performed, which tendon to
transfer or lengthen, and where to transfer it or how
much to lengthen it, to improve walking ability for a
specific child with cerebral palsy. This use of human
movement data does not yet happen in clinical practice.
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musculoskeletal models could be used for prediction
rather than assessment or identification,t h o u g hidentifi-
cation has significant clinical value as well. While pre-
diction is the most challenging use, it is also the use
with the greatest potential to improve functional out-
come on an individual patient basis.
Clinical process of personalized modeling
How should personalized neuromusculoskeletal models
be used to predict functional outcome for various treat-
ment plans under consideration? Expanded from ideas
presented by researchers at the Rizzoli Orthopedic Insti-
tute in Bologna, Italy, and Dr. Bart Koopman at the
University of Twente in Enschede, the Netherlands, we
propose a three-step process for treatment design using
personalized models:
1) Model preparation steps:
￿ Identify model outputs to be used as indicators of
clinical/functional outcome.
￿ Define model complexity required to predict these
outputs with sufficient accuracy for the intended
clinical application.
￿ Collect pre-treatment movement, strength, and
imaging data (as required) to construct the persona-
lized model and predict the outputs of interest.
2) Model construction steps:
￿ Calibrate model geometry and parameter values to
which the outputs of interest are sensitive using pre-
treatment movement, strength, and/or imaging data.
￿ Estimate model parameter values to which the
outputs of interest are insensitive using data
reported in the literature.
￿ Incorporate surgical or rehabilitation treatment
plans under consideration into the personalized
model.
3) Model utilization steps:
￿ Predict post-treatment patient function for each
proposed treatment plan.
￿ Select treatment plan and associated parameter
values that maximize functional outcome, possibly
using numerical optimization methods.
￿ Validate personalized model predictions using
post-treatment function measured from patients
whose treatment was not planned with a model.
￿ Implement optimal surgical or rehabilitation treat-
ment plan designed with the personalized model.
￿ Collect post-treatment movement, strength, and/or
imaging data from the patient to assess clinical/func-
tional outcome.
In this process, only the steps relevant to the mobility-
related clinical application at hand need be performed.
For example, clinical applications that do not require
modeling of individual muscle forces may not require
any imaging and strength data from the patient, and
thus steps related to calibration of patient-specific mus-
cle and bone geometry can be omitted. Model para-
meter values that require calibration to patient data may
necessitate collection of additional experimental data
solely for calibration purposes [1].
Two critical tasks to highlight in this process are Cali-
brate and Validate.U n l e s st h em o d e li sc a l i b r a t e dt o
relevant data collected from the patient prior to treat-
ment, the model will not be sufficiently personalized to
predict the patient’s post-treatment function. Similarly,
unless calibrated model predictions are validated using
post-treatment data collected from patients whose treat-
ments were not planned with the model, clinicians will
not have confidence in the model predictions, and per-
sonalized models will never advance toward widespread
clinical utility. Validation of treatment planning using
personalized models will ultimately require randomized
controlled trials, where outcomes are compared between
patients whose treatments were planned with a persona-
lized model and those whose treatments were not.
Clinical applications of personalized modeling
During our tour of European research labs, we sought to
identify clinical applications where a personalized mod-
eling process similar to the one outlined above was
already being followed. By the end of the tour, we made
three valuable observations related to clinical application
of personalized neuromusculoskeletal models. First, few
labs have reached the point of being able to apply this
process to specific clinical problems. Second, some of
the best existing clinical applications involved generic
rather than personalized models. Third, most clinical
applications we observed involved orthopedic surgery,
with few applications involving neurorehabilitation.
Below we comment further on these observations.
Three large projects funded by the European Commis-
sion (EC) are making significant strides in developing
and applying personalized neuromusculoskeletal models
to orthopedic clinical problems. The first is the “Osteo-
porotic Virtual Physiological Human” (VPHOP) project
[2], which involves a large consortium of academic and
industrial partners throughout Europe and is coordi-
nated by Dr. Marco Viceconti at the Rizzoli Orthopedic
Institute in Bologna, Italy [3-5]. As stated on the project
website, the goal is to “develop, validate and deploy the
next generation of technology to predict the absolute
risk of fracture in patients with low bone mass, thereby
enabling clinicians to provide better prognoses and
implement more effective treatment strategies.” One of
the unique emphases of the project is on multi-scale
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the cell, tissue, organ, and body levels to permit clini-
cally useful predictions of the risk of bone fracture in
different patient populations.
In a related project, Viceconti’st e a ma tt h eR i z z o l i
Orthopedic Institute has developed personalized neuro-
musculoskeleal models of pediatric patients who
received a surgical limb salvage procedure for bone can-
cer [4,6]. For this clinical problem, the challenge is to
determine how the patient should load the bone allo-
graft during the rehabilitation process such that bone
loads are high enough to stimulate repair but low
enough to avoid fracture. Since each clinical case is
unique, surgical and rehabilitation treatment design can-
not be standardized. Dr. Viceconti and his research
team are using gait and imaging data to create persona-
lized neuromusculoskeletal models that estimate muscle
and bone loads in the patient’s femur during walking
(Figure 1). These estimates inform the rehabilitation
process and when the patient should be cleared for full
functional loading with no restrictions. The primary
challenges faced by this personalized modeling process
are whether scaling of muscle and bone geometry from
a generic model is sufficiently accurate for this pediatric
application, and also whether the estimated muscle and
bone loads (which currently cannot be validated experi-
mentally) are sufficiently reliable.
The second large EC-funded project is called “NMS
Physiome” [7], which is also coordinated by researchers
at the Rizzoli Orthopedic Institute. This project seeks to
“promote a more organic cooperation in the develop-
ment of Predictive, Personalised and Integrative muscu-
loskeletal medicine” by integrating research efforts
between the VPHOP project and the Center for Physics-
Figure 1 Personalized modeling workflow for massive skeletal reconstruction, as developed by the Medical Technology Laboratory at
the Rizzoli Orthopedic Institute in Bologna, Italy. a) CT scan of the lower limbs performed at follow-up, with motion capture markers visible
as well. b) Focused view of reconstructed femur immediately after surgery. c) Patient-specific musculoskeletal model superimposed on CT
images (LHPBuilder, B3C, Italy). d) One frame of dynamic walking simulation performed with the patient-specific model (OpenSim). Image
courtesy of Dr. Giordano Valente, Rizzoli Orthopedic Institute, Bologna, Italy.
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Stanford University in the United States. Integration is
focused on neuromusculoskeletal software tools (MAF,
OpenSim, and FEBio) and research community websites
(BiomedTown and Simtk) developed by the two consor-
tia. The goal of integration is to address the challenges
posed by personalized neuromusculoskeletal modeling
more effectively and efficiently.
The third large EC-funded project is entitled “Improv-
ing Safety and Predictability of Complex Musculo-skele-
tal Surgery using a Patient-Specific Navigation System”
(TLEMsafe) [8], which involves a consortium of aca-
demic and industrial partners headed by the University
of Twente in Enschede, the Netherlands. The stated
goal of the project is to “create an ICT-based patient-
specific surgical navigation system that helps the sur-
geon safely reach the optimal functional result for the
patient and is a user friendly training facility for the sur-
geons.” In this project, the researchers proposed to use
personalized neuromusculoskeletal models as part of a
three-step treatment design process. The first step is
creation of the personalized model from the patient’s
movement and imaging data. The model is created
within the framework of the AnyBody musculoskeletal
modeling software developed by researchers at the Uni-
versity of Aalborg in Denmark [9] (Figure 2). The sec-
ond step is for the surgeon to perform virtual surgical
treatments on the personalized model and to identify
the optimal surgical plan for the patient. The final step
is to transfer the optimized treatment plan into a surgi-
cal navigation system to be used during actual surgery.
As part of this project, Dr. Bart Koopman of the Univer-
sity of Twente is currently investigating the use of per-
sonalized neuromusculoskeletal models to identify
optimal patient-specific tendon transfer procedures to
restore hip adductor strength in patients who walk with
a “drooping” swing leg hip (i.e., Trendelenburg gait due
to Poliomyelitis or total hip arthroplasty).
Other research we observed involved the use of gen-
eric rather than personalized neuromusculoskeletal
models. While personalized models have the greatest
potential to impact clinic practice, generic models can
still provide significant clinical benefits. Two clinical
applications of generic models were particularly well
developed. The first was the design of a total ankle
replacement by Dr. Alberto Leardini and colleagues at
the Rizzoli Orthopedic Institute in Italy [10,11]. The
design was developed using a sagittal plane musculoske-
letal model of the ankle that incorporated the ligaments
and articular surfaces. The design philosophy was to
maintain medial and lateral ankle ligaments in an iso-
m e t r i cs t a t ed u r i n gp a s s i v ea n k l em o t i o n .T h et e a m
identified a novel geometric design to achieve this goal,
using non-anatomically shaped tibial and talar compo-
nents with a meniscal bearing interposed between them.
T h ed e s i g nh a sb e e nl i c e n s e db ya no r t h o p e d i ci m p l a n t
Figure 2 Examples of musculoskeletal models developed for the TLEMsafe project. Image courtesy of Prof. Dr. Ir. Bart Koopman, University
of Twente, Enschede, the Netherlands.
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good restoration of ankle mobility with low complica-
tion and revision rates [12,13].
The other example was evaluation of tendon transfer
surgery for massive rotator cuff tears by Dr. Frans van
der Helm and colleagues at Delft University of Technol-
ogy in the Netherlands [14,15]. The evaluation was per-
formed using a high fidelity musculoskeletal shoulder
and elbow model constructed from extensive measure-
ments performed on a single cadaver specimen [16].
The model accounts for more parameters (including
muscle sarcomere length measured by laser diffraction)
than any other upper extremity model. Simulations per-
formed with the generic model have provided specific
recommendations for which tendons to transfer, and
where to transfer them, to replace the function of a torn
rotator cuff without sacrificing shoulder strength for
functional tasks. Similar to the pediatric oncology appli-
cation, the reliability of the model’s predicted clinical
outcome is only as good as the reliability of the model’s
predicted muscle forces. Dr. van der Helm and collea-
gues have attempted to validate the model’sp r e d i c t i o n
of shoulder muscle and contact forces using contact
forces measured by an instrumented shoulder prosthesis
[17]. The authors concluded that, “Although results
indicated a reasonable compatibility between model and
measured data, adjustments will be necessary to indivi-
dualize the generic model with the patient-specific
characteristics.”
The primary rehabilitation applications we observed
utilized a personalized modeling method called Comple-
mentary Limb Motion Estimation (CLME) [18,19]. The
method uses motion measurements made on a patient’s
healthy leg to predict how the patient’si m p a i r e dl e g
should move. The predictions are made in real time by
exploiting the strong coupling that exists between skele-
tal degrees of freedom during locomotion. These cou-
plings (or synergies) are identified in healthy subjects
using statistical dimensionality reduction methods (e.g.,
principal component analysis) and then applied to the
healthy limb of a patient to predict the desired motion
of the patient’s impaired limb. CLME was first proposed
to generate personalized motion trajectories for the
paretic limb of patients undergoing robotic gait training
following stroke [19]. The goal was to maintain patient
stability while minimizing unwanted interaction forces
between patient and robot. More recently the same
method has been proposed to personalize the control of
an active knee exoprosthesis to the gait patterns of
patients who have undergone above-knee amputation
[18]. For both applications, the predicted motion of the
impaired or prosthetic limb is used as a personalized
reference to be tracked by the robot or prosthesis con-
trol system. While we observed other personalized
rehabilitation applications, they did not have a strong
neuromusculoskeletal modeling component to them.
Clinical gaps in personalized modeling
Mobility-related clinical problems are typically treated
by either surgery or rehabilitation and either do or do
not possess a significant neurological component. Thus,
use of personalized neuromuscular models to improve
treatment of mobility impairments can be grouped into
four categories: 1) surgical treatment without a signifi-
cant neurological component, 2) surgical treatment with
a significant neurological component, 3) rehabilitation
treatment without a significant neurological component,
and 4) rehabilitation treatment with a significant neuro-
logical component. Of these four categories, the first is
the most developed and the fourth the least developed
in terms of personalized neuromusculoskeletal modeling.
This situation is not surprising given that technology is
a more recent addition to rehabilitation treatments (e.g.,
rehabilitation robotics) than to surgical treatments and
that neurological factors are more difficult to model
than are mechanical factors. Below we present clinical
gaps in personalized modeling for each of these four
categories.
Osteoarthritis is a prevalent disabling disease that is
commonly treated by surgical intervention. Though it
clearly possesses a neurological component [20], that
component is secondary to mechanical factors as far as
surgical treatment design is concerned. Use of persona-
lized neuromusculoskeletal models has been proposed
by European labs for pre-operative planning of high
tibial osteomities and total joint replacements [21,22].
While joint replacement surgery is generally reliable,
individual cases can pose special challenges, especially
those involving revision surgery. In contrast, high tibial
osteotomy (HTO) is a challenging surgical procedure
with highly variable outcomes but also high potential
benefits, making it an excellent target for personalized
models. Use of personalized models to design custo-
mized gait modifications following HTO surgery could
also be valuable for avoiding the loss of boney correc-
tion that often occurs over time. Anterior cruciate liga-
ment replacement to avoid knee osteoarthritis is a
related surgical application where personalized models
could be of value [23].
In contrast, cerebral palsy and Charcot-Marie-Tooth
disease are neurological disorders that are commonly
treated by surgery, since no treatment exists for the
underlying neurological problem. Though Charcot-
Marie-Tooth disease is not well known, it is the most
commonly inherited neurological disorder and limits
mobility in approximately 1 in 2,500 individuals [24].
Surgical treatments for both disorders typically involve
muscle lengthening, tendon transfer, and/or osteotomy
to improve joint range of motion, foot-ground contact
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ders, patients have varied and unique clinical presenta-
tions, making stereotypical treatment planning
ineffective. For this reason, personalized neuromusculos-
keletal models, especially those that are able to model
the neurological limitations (e.g., muscle spasticity) of
the patient, could play a valuable role in predicting the
outcome of complex multi-level surgeries that are per-
formed on these patients [25-27].
Stroke, spinal cord injury, and traumatic brain injury
significantly affect mobility, possess a major neurological
component, and are often treated by rehabilitation
methods. Personalized neuromusculoskeletal models
have yet to be applied to traditional or robot-assisted
rehabilitation treatments for these disorders. Given this
large gap, even personalized models that omit neural
control models have the potential to make a significant
clinical impact. For example, a number of clinical and
research labs in Europe are utilizing robot-assisted ther-
apy for neurorehabilitation [28,29]. Many of these labs
are using the Lokomat gait trainer (Hocoma AG, Volk-
etswil, Switzerland), whose programmed walking pattern
is that of one of the designers. Personalized musculoske-
letal models that can predict patient-specific improve-
ments in gait pattern could be used to customize robot-
prescribed gait motions. For individuals who have had a
stroke, similar models could be used to predict a
patient-specific sequence of gradual gait alterations lead-
ing to normal function, with the model indentifying
where to focus rehabilitation efforts to maximize func-
tional outcome.
Personalized musculoskeletal models that include per-
sonalized neural control models would be even more
beneficial for improving rehabilitation of neurological
disorders. Models that account for patient-specific
neural control limitations and neuroplasticity could be
used to identify the maximum expected improvement
and how best to get there. As suggested by Dr. Herman
van der Kooij of the University of Twente in the Neth-
erlands, such models could be useful for predicting how
people interact with and adapt to their environments,
which could improve the effectiveness of robotic therapy
systems. Furthermore, such models could be valuable for
the design of neuroprostheses that use functional elec-
trical stimulation to restore lost function [30,31]. For
example, if a personalized neuromusculoskeletal model
could predict a minimum set of muscles to stimulate,
and how and when to stimulate them, to restore a nor-
mal gait pattern, then the personalized prescription
could be investigated in a clinical environment. As sta-
ted by one of the researchers on our panel, “There is a
need for. . . improved models of human motor recovery
to provide a more rational framework for designing
robotic therapy control strategies.” [32].
One of the primary reasons for these clinical gaps is
lack of effective collaboration between clinical research-
ers and personalized modeling researchers. An excellent
counterexample is the Rizzoli Orthopedic Institute in
Italy, where clinicians and engineers share the same
office space and interact during clinical decision making.
These interactions create an atmosphere where clini-
cians routinely enter into the technical world and engi-
neers routinely enter into the clinical world. Such an
environment of shared intellectual investment in solving
clinical problems is critical if personalized neuromuscu-
loskeletal modeling is to make a broad impact in the
clinic.
Technical aspects of personalized modeling
Significant research efforts are currently underway in
labs throughout Europe to develop personalized neuro-
musculoskeletal modeling tools and methods. Recalling
the section above on the Clinical Process of Personalized
Modeling, the primary challenges faced by these efforts
are the Calibrate step within Model construction and
the Validate step within Model utilization.I nt h i ss e c -
tion, we discuss current technical capabilities of perso-
nalized modeling related to model calibration and
validation, followed by a discussion of technical gaps
that need to be filled if personalized neuromusculoskele-
tal models are to become clinically useful.
Technical capabilities of personalized modeling
Despite significant computational advances over the past
ten years, model personalization remains a major chal-
lenge, as does the ability to use a personalized model to
predict the outcome of a clinical intervention. Personalized
neuromusculoskeletal models can be applied to mobility-
related clinical problems only to the extent to which key
model features can be calibrated to data collected from a
patient. Thus, the ability to calibrate models to patient
data is a prerequisite to clinical use of personalized mod-
els, with the proposed clinical application determining the
extent of model personalization required.
Since most neuromusculoskeletal models are generic,
being constructed from detailed anatomic measurements
performed on cadaver specimens [16,33], a model perso-
nalization (or calibration) process is needed. Expanding
on information provided by Dr. Bart Koopman of the
University of Twente in the Netherlands, we propose
four model calibration steps that should be performed
in whole or in part to transform a generic model into a
personalized model:
1) Geometric calibration - Use of imaging data (e.g.,
MR, CT, x-ray) to calibrate bone geometry, muscle lines
of action, and muscle moment arms in a musculoskele-
tal model.
2) Kinematic calibration - Use of motion data (e.g.,
marker-based, inertial sensors, fluoroscopy) to calibrate
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body segments of a skeletal model.
3) Kinetic calibration - Use of load data (e.g., ground
reaction force and moment, foot contact pressure,
dynamometer) to calibrate body segment mass and iner-
tia, foot stiffness, muscle strength, and other muscle-
tendon properties in a neuromusculoskeletal model.
4) Neurologic calibration - Use of motion, load, and
muscle activity data (i.e., muscle EMG) to calibrate feed-
forward, intrinsic feedback, reflexive feedback, and/or
synergy properties of the neural control system in a
neuromusculoskeletal model.
The challenge is how to construct a personalized
model that is consistent with all available data from
these different modalities [34].
Current methods for geometric calibration involve
uniform scaling, non-uniform scaling, deformation, or
direct creation of bone models and muscle lines of
action from patient MR or CT data. Uniform scaling
based on external measurements is inaccurate when cal-
culating muscle moment arms, muscle-tendon lengths,
muscle forces, and joint contact forces [35], especially
when scaling a generic model of an adult to a pediatric
patient [36]. Non-uniform scaling is only slightly better
at producing accurate muscle moment arms and mus-
cle-tendon lengths [27]. Creation of patient-specific geo-
metry directly from the patient’s imaging data remains
the gold standard [26], but the process is highly time
consuming and somewhat subjective, depending on the
imaging modality and the anatomic structures being
modeled (e.g., bone edges are often poorly defined in
MR data).
Kinematic calibration involves determining fixed joint
positions and orientations in the body segments of a
skeletal model with a pre-defined kinematic structure.
The calibration process is usually performed using sur-
face marker data, with joint angles in the model being
calculated as a byproduct. European labs have used opti-
mization methods [1] and extended Kalman filter meth-
ods [37-39] to perform kinematic calibration. Filter-
based methods have the advantage of being computa-
tionally faster and less complex than most optimization
methods, but they require a greater amount of algorithm
tuning to achieve satisfactory performance. Despite
these advances, neither approach has yet to be general-
ized and incorporated into commercial-grade musculos-
keletal modeling software such as the AnyBody
program.
Kinetic calibration typically involves calibration of seg-
ment mass properties or muscle force-generating prop-
erties. Though segment mass properties can be
calibrated to force plate and motion data [40], they are
often taken from regression equations developed from
measurements performed on cadavers [41]. Similarly,
though muscle model parameter values (e.g., muscle
strength) can be calibrated to isometric and/or isokinetic
dynamometer data [42], this calibration step is usually
omitted due to the extra effort it requires. A recent Eur-
opean study indicated that subject-specific muscle-ten-
don parameter values calibrated to dynamometer data
are appropriate for use in musculoskeletal models used
to analyze gait [43]. Since many movement impairments
involve undesirable foot-ground contact patterns, kinetic
calibration of patient-specific foot-ground contact mod-
els will be essential in the future for predicting changes
in gait function due to various proposed treatments, yet
kinetic calibration methods for such models do not yet
exist.
A promising development to address geometric, kine-
matic, and kinetic calibration simultaneously is research
being performed by Dr. Wafi Skalli at Arts et Métiers
ParisTech in Paris, France using the EOS bi-plane x-ray
system (EOS Imaging SA, Paris, France). With the EOS
system, a subject stands upright while a low-dose x-ray
system scans the entire body from head to toe collecting
one continuous distortion-free image in each of two
orthogonal planes. The resulting bi-plane images are
then processed and morphed using template anatomy
for personalization and visualization. Geometric calibra-
tion of bone and muscle geometry via deformation of
template bone and muscle models can be performed
rapidly and accurately relative to geometry constructed
directly from CT data [44-47]. Kinematic calibration
could theoretically be aided by performing scans of the
relevant portion of the body in two or more poses (e.g.,
the lower extremities in different squatting positions)
[48], especially if surface markers to be used in addi-
tional movement experiments are also visible. Kinetic
calibration of segment mass properties and muscle
strength parameters (based on muscle cross sectional
areas) can also be performed from the images [49,50].
Thus, with improvements in automation and refinement
of existing algorithms, the EOS system has the potential
to improve musculoskeletal model personalization
significantly.
The remaining area, neurologic calibration, has seen
the least progress due to the significant challenges
involved in understanding how the human neural con-
trol system functions. This calibration step can be pur-
sued using a range of approaches, from a physiological
approach that seeks to model the detailed anatomy and
physiology involved in neural control, to an emergent
approach that seeks to model the neural control compu-
tations implemented by the anatomy but without model-
ing anatomic detail. An example of a physiological
approach is detailed modeling of feedforward, intrinsic
(i.e., muscle) feedback, and reflexive (i.e., visual, proprio-
ceptive, and vesitibular) feedback mechanisms utilized
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fidelity neural control models have been applied to pos-
tural control rather than movement tasks, and methods
for personalizing the parameter values in these models
are not yet well developed. At the other extreme, an
example of an emergent approach is muscle synergy
analysis, where EMG signals from a large number of
muscles (e.g., 16) are decomposed into a smaller num-
ber of basis activation signals (e.g., 5) for all muscles
plus a unique set of weights (often termed “modules”)
for each muscle that scale the activation signals [55,56].
Synergy analysis is used for dimensionality reduction (e.
g., 5 basis signals are used to reconstruct 16 EMG sig-
nals) and can identify neural control limitations in
patients following stroke [57]. Incorporation of these
limitations into personalized neuromusculoskeletal mod-
els could facilitate prediction of best possible functional
outcome. Between these two extremes is a physiological
approach that has successfully explained motor learning
using simplified feedforward and feedback models [58].
The approach uses a v-shaped learning function to
model the change in muscle feedforward commands
generated in response to kinematic errors experienced
during the previous movement trial. Computer simula-
tion of a sequence of arm movement trials performed in
different force fields revealed that the method can suc-
cessfully reproduce experimentally observed trial-to-trial
changes in muscle activations (to control force) and co-
contraction (to control impedence).
Validation of clinical predictions is the other major
challenge faced by personalized models. This challenge
can be surmounted when clinical outcome variables are
external quantities that can be easily measured (e.g., gait
speed, gait symmetry). Frequently, however, established
clinical databases use coarse ordinal scales to rank
movement ability, and mapping these scores to neuro-
mechanical models is difficult. In addition, significant
challenges remain when the outcome variables are either
internal to the body (e.g., muscle forces, joint contact
forces, bone strains) or dependent on quantities that are
internal to the body. Since such quantities cannot be
measured directly by non-invasive means, alternate
methods are needed for personalized model validation.
For example, predicted muscle forces have been evalu-
ated indirectly using in vivo joint contact force measure-
ments [17] or novel measurements (e.g., near infrared
spectroscopy) that are likely to be highly correlated with
in vivo muscle force [59].
Technical gaps in personalized modeling
As suggested by this review of current technical capabil-
ities in Europe, at least four critical technical gaps cur-
rently exist that limit the potential clinical applicability
of personalized neuromusculoskeletal models:
1) How can we make the personalized model calibra-
tion and prediction process fast and easy?
Though several excellent musculoskeletal modeling
programs exist, none of them contain functionality
that automates the model calibration process and
simplifies the model prediction process. Personalized
model calibration and prediction currently require
significant expertise and programming ability pos-
sessed by only a small number of researchers in a
limited number of research labs. Making these cap-
abilities available to the larger neuromusculoskeletal
modeling community via fast, automated algorithms
will be essential for the growth of personalized mod-
eling efforts. Ultimately, personalized modeling will
be adopted for routine clinical use only when it is
extremely easy to use.
2) How can we calibrate “unobservable” parameters to
which model predictions are sensitive?
For some clinical problems, personalized model pre-
dictions of functional outcome will be sensitive to
model parameter values that cannot be calibrated to
available data. The first step in addressing this pro-
blem is identifying when it occurs, which requires
performing sensitivity analyses that in some cases
will be limited by existing computational capabilities.
The next step is development of new experimental
methods or hardware that provide sufficiently rich
information to calibrate the parameter values needed
to develop the predictions.
3) How can we create personalized neural control
models?
Few neuromusculoskeletal models published to date
account for any level of personalized neural control
modeling. Such modeling would ideally account for
limitations in a patient’s neural control capabilities
as well as the extent of possible plasticity. Emergent
approaches for modeling neural control could be
incorporated into personalized musculoskeletal mod-
els as a starting point, while physiological models
could be refined to the point where essential model
parameters become well defined and methods for
calibrating them are developed. The ability to incor-
porate complex personalized neural control models
into personalized musculoskeletal models would
greatly expand model applicability to clinical situa-
tions, especially those involving neurorehabilitation.
4) How can we validate model-based predictions,
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and bone loads?
Validation of internal quantities that influence treat-
ment design remains a major challenge. While research-
ers continue to refine optimization and EMG-driven
methods for predicting muscle forces and related joint
and bone loads, the ability to validate these predictions
has lagged behind. Direct measurement of internal
quantities under special conditions (e.g., instrumented
implants), and the opportunity to test model-based pre-
dictions against these internal measurements, provides a
valuable avenue for model validation efforts [60]. Identi-
fication of novel approaches that utilize only existing
data collection capabilities, as well as development of
new experimental techniques, will be essential if clini-
cians are to gain confidence in treatment plans designed
with personalized neuromusculoskeletal models.
Conclusions
Neuromusculoskeletal modeling has yet to make a sig-
nificant difference in routine clinical practice. For this
situation to change, the key gaps identified above need
to be addressed by modeling researchers in close colla-
boration with clinical investigators. While the biggest
clinical gap for personalized neuromusculoskeletal mod-
eling is in neurorehabilitation, the gap for other mobi-
lity-related clinical proble m si sa l m o s ta sl a r g e .T h e
biggest technical gap is in personalized neural control
and recovery models, though issues like automation of
the model personalization process and development of
personalized foot-ground contact models are critical as
well for advancement. For clinical problems that involve
highly unique patient characteristics, stereotypical treat-
ment design is likely to yield variable functional out-
comes. These types of clinical problems are where
personalized neuromusculoskeletal models have the
greatest potential to create a positive paradigm shift in
the treatment design process.
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